Cheryl Napier

634 total citations
12 papers, 501 citations indexed

About

Cheryl Napier is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cheryl Napier has authored 12 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cheryl Napier's work include Cancer therapeutics and mechanisms (3 papers), DNA and Nucleic Acid Chemistry (3 papers) and DNA Repair Mechanisms (3 papers). Cheryl Napier is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), DNA and Nucleic Acid Chemistry (3 papers) and DNA Repair Mechanisms (3 papers). Cheryl Napier collaborates with scholars based in United States, Japan and Netherlands. Cheryl Napier's co-authors include Jan M. Woynarowski, William G. Chapman, Maryanne C. Herzig, Paul E. Juniewicz, Steven K. Koester, Dean A. Troyer, Shih-Fong Chen, John R. MacDonald, Beth Hollister and Stuart L. Emanuel and has published in prestigious journals such as Biochemistry, Cancer Research and Biochemical Pharmacology.

In The Last Decade

Cheryl Napier

12 papers receiving 484 citations

Peers

Cheryl Napier

ONCOL

PRM

Michael Grondine United States

Lora A. Tucker United States

Candice L. Horn United States

Hiroshi Koutoku Japan

Siham Djelloul France

Yahao Bu United States

Jamie Arnott United States

L. Orlandi Italy

K W Kohn United States

Akito Nakamura Japan

Michael Grondine United States

Cheryl Napier

421 ×1.4

265 ×0.9

ONCOL

39 ×0.6

76 ×1.3

67 ×1.3

PRM

Citations per year, relative to Cheryl Napier Cheryl Napier (= 1×) peers Michael Grondine

Countries citing papers authored by Cheryl Napier

Since Specialization

Citations

This map shows the geographic impact of Cheryl Napier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Napier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Napier more than expected).

Fields of papers citing papers by Cheryl Napier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Napier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Napier. The network helps show where Cheryl Napier may publish in the future.

Co-authorship network of co-authors of Cheryl Napier

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Napier. A scholar is included among the top collaborators of Cheryl Napier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Napier. Cheryl Napier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Humphries, Michael, Richard Woessner, Karyn Bouhana, et al.. (2012). Abstract 1782: Human tumor explants are better predictors of clinical trial outcome than cell line xenografts for the KSP inhibitor ARRY-520. Cancer Research. 72(8_Supplement). 1782–1782. 1 indexed citations

Bendell, Johanna C., Kyriakos P. Papadopoulos, Suzanne F. Jones, et al.. (2011). Abstract B243: A phase I dose-escalation study of MEK inhibitor MEK162 (ARRY-438162) in patients with advanced solid tumors.. Molecular Cancer Therapeutics. 10(11_Supplement). B243–B243. 26 indexed citations

Anderson, Deborah, et al.. (2009). In Vivo Activity of ARRY-380, a Potent, Small Molecule Inhibitor of ErbB2 in Combination with Trastuzumab, Docetaxel or Bevacizumab.. Cancer Research. 69(24_Supplement). 5104–5104. 7 indexed citations

Papisov, Mikhail, Alan J. Fischman, Alex Hiller, et al.. (2007). MER-1001, a novel polymeric prodrug of camptothecin, is a potent inhibitor of LS174 and A2780 human tumor xenografts in a mouse model. Cancer Research. 67. 781–781. 6 indexed citations

Emanuel, Stuart L., Terry V. Hughes, Mary Adams, et al.. (2007). Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors. Molecular Pharmacology. 73(2). 338–348. 30 indexed citations

Parker, George A., et al.. (2005). Mouse model of docetaxel neurotoxicity. Cancer Research. 65. 984–985. 1 indexed citations

Stull, Robert, Rachel Harte, Yan Lü, et al.. (2005). Expression analysis of secreted and cell surface genes of five transformed human cell lines and derivative xenograft tumors. BMC Genomics. 6(1). 55–55. 7 indexed citations

Emanuel, Stuart L., Catherine A. Rugg, Robert H. Gruninger, et al.. (2005). The In vitro and In vivo Effects of JNJ-7706621: A Dual Inhibitor of Cyclin-Dependent Kinases and Aurora Kinases. Cancer Research. 65(19). 9038–9046. 101 indexed citations

Woynarowski, Jan M., et al.. (2000). Region-Specific DNA Damage by AT-Specific DNA-Reactive Drugs Is Predicted by Drug Binding Specificity^,. Biochemistry. 39(32). 9917–9927. 16 indexed citations

10.

Woynarowski, Jan M., William G. Chapman, Cheryl Napier, & Maryanne C. Herzig. (1999). Induction of AT-specific DNA-interstrand crosslinks by bizelesin in genomic and simian virus 40 DNA. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1444(2). 201–217. 15 indexed citations

11.

Woynarowski, Jan M., William G. Chapman, Cheryl Napier, Maryanne C. Herzig, & Paul E. Juniewicz. (1998). Sequence- and Region-Specificity of Oxaliplatin Adducts in Naked and Cellular DNA. Molecular Pharmacology. 54(5). 770–777. 201 indexed citations

12.

Woynarowski, Jan M., Cheryl Napier, Steven K. Koester, et al.. (1997). Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114). Biochemical Pharmacology. 54(11). 1181–1193. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact